`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`APOTEX INC. AND APOTEX CORP.,
`Petitioners,
`v.
`
`CELGENE CORPORATION
`Patent Owner.
`________________
`
`Case IPR2018-00685
`Patent 8,741,929
`________________
`
`PATENT OWNER’S MANDATORY NOTICES
`
`
`
`
`
`
`
`Case IPR2018-00685
`Patent 8,741,929
`Patent Owner Mandatory Notices
`
`
`Celgene Corporation, the Patent Owner, provides the following mandatory
`
`notices pursuant to 37 C.F.R. § 42.8.
`
`REAL PARTY-IN-INTEREST
`
`In accordance with 37 C.F.R. § 42.8(b)(1), Patent Owner identifies Celgene
`
`Corporation (“Celgene”) as the real party-in-interest. Celgene is a corporation
`
`organized and existing under the laws of the State of Delaware, having a principal
`
`place of business at 86 Morris Avenue, Summit, New Jersey 07901, and is the
`
`owner of all right, title, and interest in U.S. Patent No. 8,741,929 (“the ’929
`
`Patent”) by virtue of an assignment from the inventor, Jerome B. Zeldis. The
`
`Assignment was recorded on September 16, 2010 at Reel 024995, Frame 0398.
`
`RELATED MATTERS
`
`Pursuant to 37 C.F.R. § 42.8(b)(2), Patent Owner identifies the following:
`
`A.
`
`Litigations Involving the Patent-at-Issue
`
`The ’929 Patent is the subject of the following pending litigation:
`
`• Celgene Corp. v. Apotex Inc., No. 2:18-cv-00461-SDW-LDW
`
`(D.N.J. Jan. 11, 2018).
`
`LEAD AND BACKUP COUNSEL AND SERVICE INFORMATION
`
`In accordance with 37 C.F.R. §§ 42.8(b)(3), 42.8(b)(4), and 42.10(a), Patent
`
`Owner identifies the following lead and backup counsel and service information:
`
`
`
`1
`
`
`
`Case IPR2018-00685
`Patent 8,741,929
`Patent Owner Mandatory Notices
`
`
`Lead Counsel:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`F. Dominic Cerrito (Reg. No. 38,100)
`Quinn Emanuel Urquhart & Sullivan, LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7000
`Fax: (212) 849-7100
`Email: nickcerrito@quinnemanuel.com
`
`Backup Counsel:
`
`J. Patrick Elsevier, Ph.D. (Reg. No.
`44,668)
`Celgene Corporation
`86 Morris Avenue
`Summit, NJ 07901
`Tel: (908) 673-9000
`Email: pelsevier@celgene.com
`
`
`Christopher J. Harnett (Reg. No.
`35,538)
`Jones Day
`250 Vesey Street
`New York, NY 10281
`Tel: (212) 326-3939
`Fax: (212) 755-7306
`Email: charnett@jonesday.com
`Anthony M. Insogna (Reg. No. 35,203)
`Jones Day
`4655 Executive Drive, Suite 1500
`San Diego, CA 92121
`Tel: (858) 314-1200
`Fax: (844) 345-3178
`Email: aminsogna@jonesday.com
`
`Andrew S. Chalson (pro hac vice)
`Quinn Emanuel Urquhart & Sullivan,
`LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7112
`Fax: (212) 849-7100
`Email:
`andrewchalson@quinnemanuel.com
`Frank C. Calvosa (Reg. No. 69,064)
`Quinn Emanuel Urquhart & Sullivan,
`LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7112
`Fax: (212) 849-7100
`Email: frankcalvosa@quinnemanuel.com
`Daniel C. Wiesner (pro hac vice)
`Quinn Emanuel Urquhart & Sullivan,
`LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7112
`Fax: (212) 849-7100
`Email:
`danielwiesner@quinnemanuel.com
`
`
`
`
`
`2
`
`
`
`Case IPR2018-00685
`Patent 8,741,929
`Patent Owner Mandatory Notices
`
`
`Patent Owner consents to electronic service by email.
`
`Pursuant to 37 C.F.R. § 42.10(b), a Power of Attorney is being submitted to
`
`the Board herewith.
`
`
`
`
`
`
`
`Date: March 16, 2018
`
` Respectfully submitted,
`
`By: /F. Dominic Cerrito/
`F. Dominic Cerrito
`(Reg. No. 38,100)
`Quinn Emanuel Urquhart &
`Sullivan, LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7000
`Fax: (212) 849-7100
`nickcerrito@quinnemanuel.com
`
`
`
`
`
`
`3
`
`
`
`
`
`Case IPR2018-00685
`Patent 8,741,929
`Patent Owner Mandatory Notices
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I certify that I caused to be served on the
`
`counsel for Petitioners a true and correct copy of the foregoing “Patent Owner’s
`
`Mandatory Notices” and the document captioned “Power of Attorney For
`
`Proceedings Before the Patent Trial and Appeal Board” by electronic means on
`
`March 16, 2018 at the following email addresses of record :
`
`Lead Counsel
`John J. Molenda (Reg. No. 47,804)
`STEPTOE & JOHNSON LLP
`1114 Ave. of the Americas
`New York, NY 10036
`Tel: (212) 506-3900
`Fax: (212) 506-3950
`email: lenalidomide@steptoe.com
`
`
`
`
`Date: March 16, 2018
`
`
`
`
`
`Backup Counsel
`Vishal Gupta (Reg. No. 67,284)
`STEPTOE & JOHNSON LLP
`1114 Ave. of the Americas
`New York, NY 10036
`Tel: (212) 506-3900
`Fax: (212) 506-3950
`email: lenalidomide@steptoe.com
`Won Seon Choi (Reg. No. 73,012)
`STEPTOE & JOHNSON LLP
`1114 Ave. of the Americas
`New York, NY 10036
`Tel: (212) 506-3900
`Fax: (212) 506-3950
`email: lenalidomide@steptoe.com
`
`/F. Dominic Cerrito (Reg. No. 38,100)/
`F. Dominic Cerrito (Reg. No. 38,100)
`Quinn Emanuel Urquhart &
`Sullivan, LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Tel: (212) 849-7000
`Fax: (212) 849-7100
`nickcerrito@quinnemanuel.com
`
`4
`
`